Tuesday’s Midday Movers: Anthera Pharmaceuticals (ANTH), Pixelworks (PXLW), Kandi Technologies (KNDI), LendingClub Corp (LC), Caladrius Biosciences (CLBS)

By Carrie Williams

So far Tuesday, July 9, NASDAQ is up 3.23% and the S&P is up 1.2%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Anthera Pharmaceuticals (ANTHResearch Report), Pixelworks (PXLWResearch Report), Kandi Technologies (KNDIResearch Report), LendingClub Corp (LCResearch Report) and Caladrius Biosciences (CLBSResearch Report).

Anthera Pharmaceuticals is up 25.89% in midday trading to $0.06. Shares opened today at $0.05. The company has a 52-week low of $0.01 and a 52-week high of $0.00.

Pixelworks is up 8.33% in midday trading to $3.25. Shares opened today at $3.00. The company has a 52-week low of $2.60 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $6.00, marking a 100.00% potential upside from current levels. In a report issued on May 3, Northland Securities analyst Gus Richard assigned a Buy rating on PXLW, with a price target of $6, which represents a potential upside of 100% from where the stock is currently trading. Over the last 3 months, the insider sentiment on Pixelworks has been positive based on 18 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

Kandi Technologies is up 7.84% in midday trading to $5.50. Shares opened today at $5.10. The company has a 52-week low of $3.54 and a 52-week high of $0.00. Over the last 3 months, the insider sentiment on Kandi Technologies has been positive based on 13 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

LendingClub Corp is up 7.72% in midday trading to $15.62. Shares opened today at $14.50. The company has a 52-week low of $12.30 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $8.85, marking a -38.97% potential downside from current levels. In a report released yesterday, Morgan Stanley analyst James Faucette maintained a Hold rating on LC, with a price target of $23.75, which represents a potential upside of 64% from where the stock is currently trading. Separately, on June 16, BTIG’s Mark Palmer reiterated a Buy rating on the stock and has a price target of $6. Over the last 3 months, the insider sentiment on LendingClub Corp has been negative based on 72 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Caladrius Biosciences is up 7.49% in midday trading to $2.69. Shares opened today at $2.50. The company has a 52-week low of $2.16 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $10.42, marking a 316.38% potential upside from current levels. In a report issued on May 14, WBB analyst Stephen Brozak initiated coverage with a Buy rating on CLBS and a price target of $6.75, which implies an upside of 170% from current levels.

Trending Stocks Based on Insider Activity >>